Factorial Design−Driven Optimization of Zein−Chitosan Nanoparticles for Oral Delivery of Silibinin
ACS Omega · 17.03.2026 · 11 (10) · 16673-16686
DOI: 10.1021/acsomega.5c13167 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 06.03.2026. Verfasst von Rafaelle de Sertorio Dos Santos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Nanostructured Formulations, Midwest State University - UNICENTRO, Alameda Élio Antonio Dalla Vecchia St. 838, Guarapuava, Paraná 85040…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico, Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior.
Abstract (Originalsprache)
High Resolution Image Download MS PowerPoint Slide Silibinin (SLB) is a poorly water-soluble flavonolignan with relevant therapeutic potential but limited oral bioavailability. In this study, SLB-loaded zein−chitosan nanoparticles (SLB-ZNP) were developed by nanoprecipitation and optimized using a full 2 4 factorial design to investigate the effects of zein concentration, chitosan concentration, incubation time, and organic-to-water ratio on particle size, polydispersity index (PDI), zeta potential, and encapsulation efficiency. The factorial approach enabled systematic evaluation of the most influential variables and their interactions, with zein and chitosan concentrations exerting major effects on particle size and surface charge, while the organic-to-water ratio significantly affected particle size distribution. The optimized formulation produced nanoparticles with a mean diameter of approximately 145 nm, low PDI (∼0.19), high positive zeta potential (∼+40 mV), and high encapsulation efficiency (∼90%). Transmission electron microscopy revealed spherical and homogeneous nanoparticles, with enhanced structural organization upon SLB incorporation. In vitro cytotoxicity assays in HeLa and SiHa cervical cancer cell lines showed that nanoencapsulation modulates carrier-associated cytotoxicity in a cell line- and concentration-dependent manner. Overall, this study demonstrates the utility of factorial design as a formulation-centered strategy for engineering zein−chitosan nanoparticles with well-defined physicochemical and in vitro properties.
Autor:innen und Institutionen
- Laboratory of Nanostructured Formulations, Midwest State University - UNICENTRO, Alameda Élio Antonio Dalla Vecchia St. 838, Guarapuava, Paraná 85040-167, Brazil.
- Pharmacy Department, Maringa State University - UEM, Avenida Colombo, St.5790, Jardim Universitário, Maringá, Paraná 87020-900, Brazil.
- Chemistry Department, Federal Technological University of Paraná - UTFPR, Via do Conhecimento, s/n - KM 01 - Fraron, Pato Branco, Paraná 85503-390, Brazil.
ORCID-Profile: Ariane Krause Padilha Lorenzett, Rubiana Mara Mainardes
Förderung
- Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico
- Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior
Zitieren
APA
Dos Santos, R. S., Padilha Lorenzett, A. K., de Matos, G. C. G., de Souza Bonfim-Mendonça, P., de Lima, V. A., & Mainardes, R. M. (2026). Factorial Design−Driven Optimization of Zein−Chitosan Nanoparticles for Oral Delivery of Silibinin. ACS Omega, 11(10), 16673-16686. https://doi.org/10.1021/acsomega.5c13167
Vancouver
Dos Santos RS, Padilha Lorenzett AK, de Matos GCG, de Souza Bonfim-Mendonça P, de Lima VA, Mainardes RM. Factorial Design−Driven Optimization of Zein−Chitosan Nanoparticles for Oral Delivery of Silibinin. ACS Omega. 2026;11(10):16673-16686. doi:10.1021/acsomega.5c13167
BibTeX
@article{DosSantos2026,
author = {Dos Santos, Rafaelle de Sertorio and Padilha Lorenzett, Ariane Krause and de Matos, Gabriela Casa Grande and de Souza Bonfim-Mendonça, Patrícia and de Lima, Vanderlei Aparecido and Mainardes, Rubiana Mara},
title = {Factorial Design−Driven Optimization of Zein−Chitosan Nanoparticles for Oral Delivery of Silibinin},
journal = {ACS Omega},
year = {2026},
volume = {11},
number = {10},
pages = {16673--16686},
doi = {10.1021/acsomega.5c13167}
}
EUVIMED